Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer
Pancreatology · 2024
DOI: 10.1016/j.pan.2024.02.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2024. Verfasst von Nicholas F Brown und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, …. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK London Research Institute, Pancreatic Cancer Research Fund, Medical Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK.
- Spirogen, QMB Innovation Centre, 42 New Road, London, E1 2AX, UK.
- ADC Therapeutics (UK) Ltd, Translation & Innovation Hub Building, Imperial College White City Campus, 84 Wood Lane, London, W12 0BZ, UK.
- Cancer Research UK Drug-DNA Interactions Research Group, University College London Cancer Institute, 72 Huntley Street, London, WC1E 6BT, UK.
- Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK. Electronic address: j.f.marshall@qmul.ac.uk.
Förderung
- Cancer Research UK London Research Institute
- Pancreatic Cancer Research Fund
- Medical Research Council
Zitieren
APA
Brown, N. F., Murray, E. R., Cutmore, L. C., Howard, P., Masterson, L., Zammarchi, F., Hartley, J. A., van Berkel, P. H., & Marshall, J. F. (2024). Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer. Pancreatology. https://doi.org/10.1016/j.pan.2024.02.013
Vancouver
Brown NF, Murray ER, Cutmore LC, Howard P, Masterson L, Zammarchi F, et al. Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer. Pancreatology. 2024. doi:10.1016/j.pan.2024.02.013
BibTeX
@article{Brown2024,
author = {Brown, Nicholas F and Murray, Elizabeth R and Cutmore, Lauren C and Howard, Philip and Masterson, Luke and Zammarchi, Francesca and Hartley, John A and van Berkel, Patrick H and Marshall, John F},
title = {Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer},
journal = {Pancreatology},
year = {2024},
doi = {10.1016/j.pan.2024.02.013}
}
EUVIMED